Valuation: Astellas Pharma Inc.

Market Cap 4,02500Cr 2.55TCr 2.27TCr 2.12TCr 1.93TCr 3.64TCr 2,45300Cr 3.67TCr 26TCr 9.92TCr 1,25400Cr 9.58TCr 9.37TCr P/E 2027 *
10.5x
P/E 2028 * 11.1x
Enterprise Value 3,96600Cr 2.51TCr 2.23TCr 2.09TCr 1.9TCr 3.58TCr 2,41700Cr 3.62TCr 25TCr 9.78TCr 1,23600Cr 9.44TCr 9.24TCr EV / Sales 2027 *
1.69x
EV / Sales 2028 * 1.62x
Free-Float
98.92%
Yield 2027 *
3.57%
Yield 2028 * 3.7%
1 day+2.80%
1 week-5.30%
Current month-2.34%
1 month-1.57%
3 months+10.62%
6 months-11.00%
Current year+12.31%
1 week 12.5
Extreme 12.5
12.9
1 month 11.9
Extreme 11.9
13.2
Current year 11
Extreme 11
14.19
1 year 8.56
Extreme 8.56
14.19
3 years 7.53
Extreme 7.534
14.19
5 years 7.53
Extreme 7.534
15.62
10 years 7.53
Extreme 7.534
16.7
Manager TitleAgeSince
Chief Executive Officer 64 10/02/2023
Director of Finance/CFO 55 01/11/2023
Compliance Officer - 01/04/2025
Director TitleAgeSince
Chairman 66 10/02/2023
Director/Board Member 64 01/06/2019
Director/Board Member 59 01/06/2023
Change 5-day change 1-year change 3-year change Capi.($)
+2.80%-5.30% - - 2.63TCr
-0.87%-3.61%+39.13%+111.91% 1,02500Cr
-1.17%-5.52%+37.79%+65.17% 62TCr
+0.72%-1.07%+10.55%+76.41% 46TCr
-0.17%-3.43%+60.51%+40.10% 35TCr
-0.95%-4.05%+21.60%+39.37% 34TCr
-1.46%-2.89%+11.84%+24.60% 27TCr
-1.35%-5.43%-4.69%+8.40% 25TCr
-1.07%-2.86%+35.42%+51.23% 22TCr
-2.13%-4.26%+30.70%+95.01% 18TCr
Average -0.61%-1.89%+26.98%+56.91% 41.31TCr
Weighted average by Cap. -0.83%-2.11%+30.31%+68.65%

Financials

2027 *2028 *
Net sales 2,34700Cr 1.49TCr 1.32TCr 1.23TCr 1.12TCr 2.12TCr 1,43000Cr 2.14TCr 15TCr 5.79TCr 73TCr 5.59TCr 5.46TCr 2,18900Cr 1.39TCr 1.23TCr 1.15TCr 1.05TCr 1.98TCr 1,33400Cr 2TCr 14TCr 5.4TCr 68TCr 5.21TCr 5.1TCr
Net income 37TCr 232.56Cr 206.63Cr 192.86Cr 175.78Cr 331.53Cr 22TCr 334.61Cr 2.33TCr 904.39Cr 11TCr 873.16Cr 854.21Cr 35TCr 219.1Cr 194.67Cr 181.7Cr 165.61Cr 312.34Cr 21TCr 315.25Cr 2.2TCr 852.06Cr 11TCr 822.63Cr 804.77Cr
Net Debt -5.92TCr -38Cr -33Cr -31Cr -28Cr -53Cr -3.61TCr -54Cr -376.55Cr -145.91Cr -1.84TCr -140.87Cr -137.81Cr -48TCr -304.75Cr -270.77Cr -252.72Cr -230.34Cr -434.43Cr -29TCr -438.47Cr -3.06TCr -1.19TCr -15TCr -1.14TCr -1.12TCr
Logo Astellas Pharma Inc.
Astellas Pharma Inc is a Japan-based company mainly engaged in the research, development, manufacture and sales of pharmaceutical products. The Company mainly operates Pharmaceutical Products business segment. The main products include XTANDI, BETANIS, MIRABETRIC, BETMIGA and new products ZOSPATA, EVERENZO and ENHOLTUMAB VEDOTIN, among others.
Employees
14,099
Date Price Change Volume
02/26/02 €12.50 0.00% 0
01/26/01 €12.50 -2.34% 200
30/26/30 €12.80 +1.59% 0
29/26/29 €12.60 -2.33% 0
28/26/28 €12.90 -2.27% 0
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
2,245.00JPY
Average target price
2,529.29JPY
Spread / Average Target
+12.66%

Quarterly revenue - Rate of surprise